STAT June 15, 2024
Patrick Skerrett

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a Letter to the Editor here, or find the submission form at the end of any First Opinion essay.

Curing rare childhood diseases will falter unless Congress steps up,” by Joe and Courtney Dion

My heart breaks for the Dion family who desperately deserve hope for a cure to the ultra-rare disease that afflicts their children, Peter and Maggie. Sadly, they are not alone:...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Under Trump, Future Of Harm Reduction Policies To Curb Drug Overdoses Is Unclear
Pulling Out the Rug on Informed Consent — New Legal Threats to Clinicians and Patients
COVID-19 Had Worst Disease Outcomes Among Respiratory Viruses
Visualizing Drug Use Trends in U.S. Young Adults
Americans split on using weight loss drugs to treat obesity: Survey

Share This Article